Untitled 1
Geriatric Oral Medicine
Summary | About the Author
| Case Study |
View Presentation |
Assessment
Summary
Recognition and Treatment of Common Oral Lesions/Conditions in the
Elderly
Common Oral Mucosal Conditions in the Elderly
Oral
mucosal diseases and lesions are common in the elderly (1). Many older
adults have pigmented (varices, lingual varicosities, melanotic macules),
benign soft tissue (fibromas, Fordyce granules), and hard tissue conditions
(exostoses, tori). Tongue conditions include geographic tongue, black hairy
tongue, lingual varicosities, and atrophy of filiform and fungiform papillae
(2). The tongue may be fissured, coated, or enlarged (especially in
edentulous individuals). A smooth, bald, or shiny tongue can indicate a
nutritional or hematological disorder (e.g. iron or folate deficiency).
A variety of vesiculobullous and ulcerative mucosal conditions affect the
elderly. Many lesions are attributed to local trauma, such as
denture-related irritation, accidental biting, and sharp dental and
restorative surfaces. An ill-fitting denture can also cause inflammation
(denture-induced stomatitis or papillary hyperplasia) and atrophy (resorption
of residual alveolar ridges). Persistent low-grade irritation by an
ill-fitting denture can induce a hyperplastic reaction leading to formation
of an epulis fissuratum or traumatic hyperkeratosis. Oral vesiculobullous
diseases in older adults include lichen planus, pemphigus vulgaris, and
cicatricial pemphigoid (2). The most common condition is lichen planus, a
recurrent, chronic, inflammatory, auto-immune mucocutaneous disorder that
affects approximately 1% of the population of which about 35% are aged 50+
years (3). Lichenoid mucosal lesions can also be caused by a variety of
medications commonly prescribed in older patients (e.g. acyclovir, gold
salts, methyldopa, thiazide diuretics). Pemphigus vulgaris is a potentially
serious autoimmune vesiculobullous disorder that usually affects individuals
in their fifth and sixth decades of life. Cicatricial pemphigoid is another
immunologically-mediated disorder that affects primarily older women.
Prolonged use of dentures in any of these conditions can cause exacerbation
of oral mucosal lesions. Recurrent aphthous stomatitis is less common among
the elderly, however nutritional and hematological deficiencies common in
older adults can predispose to recurrent ulcers (4). Erythema multiforme is
also an unusual occurrence among the elderly, but can develop and persist
especially in immunocompromised persons.
Oral cancer is the most significant oral mucosal disease in older adults.
Incidence rates increase with age, with over 95% of all oral cancers
occurring in individuals aged 45+ years (5). In 2000, 30,000 cases were
diagnosed with approximately 8,000 deaths in the USA (6). The most common
premalignant oral lesion is leukoplakia, and the incidence of leukoplakic
lesions undergoing malignant transformation rises sharply with age. The
mortality rates for oral cancer also increase with age, and are high
compared to other cancers with overall 5-year survival rates of only 50%
(5). Typical sites of oral malignancy in the elderly include the tongue,
lips, buccal mucosa, floor of mouth, and posterior oral-pharynx. The most
common risk factors are increased age, and the use of tobacco and alcohol.
Approximately 90% of all oral cancers are squamous cell carcinomas, with the
remaining 10% being salivary, bone, or lymphoid cancers (7). These lesions
can appear as exophytic, poorly-demarcated, ulcerated, erythroplakic and/or
leukoplakic masses, and metastasize to regional lymph nodes before involving
distant organs.
Common Oral Infectious Diseases in the Elderly
Older
adults are more susceptible to develop opportunistic oral infections due to
numerous age- and disease-related changes in the oral and systemic immune
systems. Viral, fungal, and bacterial organisms invade, infect, and become
latent in the hard and soft tissues of the oral-pharyngeal region,
predisposing a person to disseminated systemic infections (8). The most
common viral infections come from the herpes family (herpes simplex virus
[HSV] and varicella zoster virus [VZV]). Initial infections typically occur
in childhood, and then viruses remain dormant in sensory ganglia until
reactivation occurs secondary to immunosuppression, trauma, stress,
sunlight, gastrointestinal disturbances, or concurrent infections. The
clinical presentation in an older adult will be similar to a younger person,
but lesions may persist longer due to concomitant immunocompromising
conditions. Shingles or VZV is an acute condition with very painful and
frequently incapacitating oral-facial lesions. The incidence exceeds 10 per
1,000 annually in adults aged 80+ years, and is most common in
immunocompromised patients (9). VZV is acquired during childhood from
exposure to chickenpox. It is then reactivated causing vesicular eruptions
on the skin and mucous membranes in the areas following the unilateral
distribution of ophthalmic, maxillary, or mandibular divisions of trigeminal
sensory nerves. Post-herpetic neuralgia has dangerous sequelae, including
blindness, facial paralysis, auditory deficits, and vertigo (10). It occurs
more frequently in older patients; more than 50% of zoster patients over 60
years old will develop poster herpetic neuralgia which may persist for
months and even years (9).
The most frequent oral fungal infection in older adults is caused by
Candida albicans (11). Several oral and systemic conditions in older adults
lead to fungal proliferation and subsequent development of infectious
diseases. Removable dental prostheses, poor oral and/or denture hygiene,
endocrine disorders (e.g. diabetes), underlying immunosuppression,
nutritional deficiencies, salivary gland hypofunction, and medications (e.g.
antibiotics, corticosteroids, immunosuppressants, cytotoxic agents) have all
been associated with oral fungal infections. The loss of vertical dimension,
and drooling problems secondary to cerebrovascular accidents, create a moist
environment in the labial commissures that also favor yeast infection. The
most common bacterial infections are associated with new and recurrent
dental caries (e.g. Streptococcus mutans, lactobacillus), periodontal
diseases (e.g. Porphyromonas gingivalis, Treponema denticola), and acute and
chronic salivary infections (e.g. Staphylococcus aureus, Streptococcus
viridens).
Salivary Gland Disorders in the Elderly
Salivary
gland dysfunction seen in older persons can be a result of local and
systemic disease, head and neck radiation treatment, chemotherapy,
immunologic disorders, and prescription and non-prescription medication
intake(12-14). Obstructions (due to mucous plugs or calcifications) and
acute/chronic bacterial infections cause salivary dysfunction. Sjögren's
syndrome is an autoimmune disease affecting exocrine glands (salivary and
lacrimal) in predominantly older females, and salivary dysfunction is a
common sequelae with associated complaints of dry eyes and dry mouth (15).
Other systemic conditions common in the elderly such as Alzheimer's,
diabetes, and dehydration have been implicated in salivary gland
hypofunction. Finally, numerous prescription and non-prescription
medications frequently taken by older persons cause salivary hypofunction
(14). Many common drugs are antidepressants, antihypertensives,
antiParkinsonian drugs, antipsychotics, antihistamines which have been
reported to cause xerostomia and salivary dysfunction. Extraoral
manifestations of salivary gland dysfunction include candidiasis in the
labial commissures and dry, cracked lips. Parotid or submandibular
enlargement with associated pain and suppuration may indicate infections or
ductal obstructions. The intraoral sequelae of insufficient salivary
production are dental caries, gingivitis, materia alba, candidiasis, poorly
fitting dentures, dysphagia, dysgeusia, and altered mastication and
deglutition (12). These oral and pharyngeal problems can have serious
consequences to an older adult. Impaired food and beverage intake can result
in malnutrition and dehydration. Recurrent oral infections and impaired oral
immunity can lead to aspiration pneumonia and systemic opportunistic
infections.
Prevention and Treatment of Oral Mucosal Conditions in the
Elderly
Prevention of oral cancer begins with the elimination of
established risk factors (e.g. tobacco, alcohol). Early detection and
recognition through regular comprehensive extra- and intra-oral examinations
in dentate and edentulous persons will enhance the prognosis and reduce the
morbidity and mortality associated with cancer and its treatments (7). Oral
cancer is treated by surgery, chemotherapy, and radiotherapy, which also
have significant oral sequelae including stomatitis, dysphagia, dysgeusia,
pain, paresthesias, facial disfigurement, oral motor dysfunction, salivary
hypofunction, and an increased risk of developing osteoradionecrosis.
Comprehensive dental management before, during, and after treatment is
essential to prevent complications. Importantly, older edentulous
individuals are four times less likely to see a dentist than dentate
individuals (16), and therefore should be targeted for regular annual head
and neck cancer examinations (17, 18).
Treatment of traumatic oral lesions begins with elimination of underlying
factors. The most common is repair of an ill-fitting denture flange/base, or
removal of an epulis fissuratum. Palliative topical medications (analgesics)
are helpful, and antibiotic coverage to prevent secondary bacterial
infection should be considered in the immunocompromised patient. For most
oral vesiculobullous and erosive diseases, therapy depends upon the severity
of the condition, ranging from mild topical steroids and oral rinses to
strong topical steroids to systemic steroids with or without
immunosuppressant agents (2). When high dose steroids are considered,
dentists should consult with the patient's physicians, especially if an
older patient has concurrent medical problems such as diabetes, coronary
heart disease, hypertension, osteoporosis, or depression.
Prevention and Treatment of Oral Infectious Diseases in the
Elderly
Prevention of the spread of viral lesions in the elderly
can be accomplished by avoiding individuals with active infections. Herpes
simplex and zoster lesions are usually self-limiting. Therefore, supportive
measures are necessary to maintain adequate nutritional and fluid intake and
diminish pain. However, early diagnosis can diminish morbidity in older
patients. In particular, immunocompromised adults are susceptible to
recurrent herpes infections, and they require immediate and aggressive
antiviral treatment. Patients with renal insufficiency should receive
adjusted antiviral doses (acyclovir, valacyclovir, famciclovir).
Post-herpetic neuralgia requires analgesics, tricyclic antidepressants, and
sometimes steroids (2).
Candidiasis prevention involves meticulous oral and denture hygiene,
judicious use of antibiotics and immunosuppressants, and elimination of
underlying local and systemic etiologic factors (e.g. salivary hypofunction,
diabetes, immunodeficiency). Comprehensive management of oral candidiasis is
usually successful with antifungal creams, rinses, and lozenges, but
persistent infections require systemic antifungal agents (11, 19). Dentures
are frequent sources of fungal infections, and require antifungal therapy
with a 10-15 minute 1% sodium hypochlorite soak and antifungal creams during
use.
Prevention and Treatment of Salivary Gland Disorders in the
Elderly
Disorders of the salivary glands require accurate
diagnosis in order to prevent the development of long-term oral and
pharyngeal complications (20). Identifying individuals at risk for
developing salivary hypofunction (e.g., those taking multiple medications
with xerostomic effects, individuals with a history of head and neck
radiotherapy or Sjögren’s syndrome) will also help prevent the oral sequelae
of salivary disorders. Salivary gland infections require diagnostic culture
and sensitivity tests, and appropriate antibiotic therapy. Amoxicillin and
clavulanic acid (clindamycin if penicillin-allergic) should be immediately
prescribed and monitored until the culture and sensitivity report is
received. Diagnosis of salivary gland obstructions may require imaging tests
(radiographs, sialograms, technetium-99 pertechnetate scans), with
subsequent removal of the obstruction. Systemic diseases (e.g. Sjögren’s
syndrome) should be identified, managed and controlled. In
medication-associated xerostomia, drug elimination or reduction is the ideal
solution in collaboration with the patient’s physician (14). However, if
this cannot be achieved, substitution of one xerostomia-causing medication
for another similar drug with fewer undesirable side effects or altered
medication dosing schedules should be considered. For patients receiving
head and neck radiation therapy for oral-pharyngeal cancers, contralateral
parotid preservation techniques are effective which can help diminish
post-irradiation xerostomia (21).
Patients with salivary hypofunction who have some remaining viable
salivary parenchymal tissue will respond to salivary stimulants. These
include sugarless candies, mints, gums, frequent use of non-sugared
beverages (20), and pilocarpine (5 to 7.5 mg tid and qhs, 22, 23) or
cevimeline (30 mg tid, 24). These cholinergic agonists (pilocarpine and
cevimeline) are contraindicated in patients with narrow angle glaucoma,
congestive heart disease, and pulmonary disease, and major side effects are
sweating and diarrhea. If there is little or no remaining viable salivary
gland tissue, saliva substitutes (25) and frequent intake of non-sugared
beverages are necessary. In dry climates, a humidifier may also help relieve
xerostomic complaints. Finally, it is vital that precautions be taken to
prevent the deleterious sequelae of salivary gland dysfunction. These
precautions include frequent dental recall, daily use of fluorides, brushing
and flossing after each meal, and rigorous prosthesis hygiene.
References
-
Hand JS, Whitehill JM. The prevalence of oral mucosal lesions in an
elderly population. J Amer Dent Assoc 1986;112(1):73-6.
-
Ship JA, Mohammad AR. Clinician's Guide to Oral Health in Geriatric
Patients. 1st ed. Baltimore, MD: American Academy of Oral Medicine;
1999.
-
Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, et al.
Update on oral lichen planus: etiopathogenesis and management. Crit Rev
Oral Biol Med 1998;9(1):86-122.
-
Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous
stomatitis. Quintessence Int 2000;31:95-112.
-
NCI. SEER Cancer Statistics Review,
1973-1996;
1996.
-
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer Statistics, 2000. Ca
Cancer J Clin 2000;50:7-33.
-
Silverman SJ. Oral Cancer. 4th ed. Hamilton, Canada: The American Cancer
Society, Inc.; 1998.
-
Shay K, Ship JA. The importance of oral health in the older patient. J
Amer Geriatr Soc 1995;43(12):1414-1422.
-
Gershon AA. Epidemiology and management of postherpetic neuralgia. Sem
Dermatol 1996;15(2 Suppl 1):8-13.
-
Heft MW. Orofacial pain. Clin Geriatr Med 1992;8(3):557-68.
-
Peterson DE. Oral candidiasis. Clin Geriatr Med 1992;8(3):513-27.
-
Fox PC. Management of dry mouth. Dent Clin N Amer 1997;41(4):863-876.
More information
-
Närhi TO, Meurman JH, Ainamo A. Xerostomia and hyposalivation: causes,
consequences and treatment in the elderly. Drugs Aging
1999;15(2):103-16.
-
Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth--2nd
edition. Gerodontology 1997;14(1):33-47.
-
Atkinson JC, Fox P. Sjogren's syndrome: oral and dental considerations.
J Amer Dent Assoc 1993;124(3):74-86.
-
Gift HC, Newman JF. How older adults use oral health care services:
results of a National Health Interview Survey. J Amer Dent Assoc
1993;124(1):89-93.
-
Guggenheimer J, Hoffman RD. The importance of screening edentulous
patients for oral cancer. J Prosthet Dent 1994;72(2):141-3.
-
Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society
Guidelines for the Early Detection of Cancer. Ca Cancer J Clin
2000;50(1):34-49.
-
Shay K, Truhlar MR, Renner RP. Oropharyngeal candidosis in the older
patient. J Amer Geriatr Soc 1997;45(7):863-70.
-
Atkinson JC, Wu A. Salivary gland dysfunction: causes, symptoms,
treatment. J Amer Dent Assoc 1994;125(4):409-16.
-
Henson BS, Eisbruch A, D'Hondt E, Ship JA. Two-year longitudinal study
of parotid salivary flow rates in head and neck cancer patients
receiving unilateral neck parotid-sparing radiotherapy treatment. Oral
Oncol 1999;35(3):234-241.
Learn more:
-
Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al.
Oral pilocarpine for post-irradiation xerostomia in patients with head
and neck cancer. N Engl J Med 1993;329(6):390-5.
-
Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, 3rd,
Tran-Johnson TK, et al. Pilocarpine tablets for the treatment of dry
mouth and dry eye symptoms in patients with Sjogren syndrome: a
randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01
Study Group. Arch Int Med 1999;159(2):174-81.
-
Cevimeline (Evoxac) for dry mouth. Med Ltr Drug Therap 2000;42(1084):70.
http://www.evoxac.com/
http://www.evoxac.com/hcp/induce-salivary-flow.html
-
Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic
polymer saliva substitute in reducing oral complaints of patients
suffering from irradiation-induced xerostomia. Quintessence Int
1998;29(6):383-8.